HeartBEATS from Lifelong Learning™

In this episode, leading experts identify key elements of an obstetric and postpartum history that may signal later life cardiovascular risk. Learn about relevant tools and crucial strategies to guide cardiovascular disease prevention efforts. 

During this episode a panel of experts discuss the patient journey through the interpretation and application of safety and efficacy data to establish and maintain protocols designed to address optimal VTE treatment pathways. Claim CE and MOC Credit at bit.ly/VTEPJ6 

Experts explore and summarize the epidemiology of arrhythmias seen during pregnancy and in the postpartum period. The discussion includes guideline directed treatment for arrhythmias during pregnancy incorporating the safety of medications and invasive treatments, as well as recommendations for care during postpartum. 

In this episode learn how key elements from a woman's pregnancy history may impact her lifelong risk for cardiovascular disease. As patients transition in the postpartum stage, recognizing social determinants of health and incorporating counseling strategies into routine care presents an opportunity to focus on health lifestyle choices. Explore the growning field of available tools, like Life's Essential 8, to support the transition of postpartum care to the primary care setting. 

In this episode, a panel of experts discuss existing and emerging VTE (venous thromboembolism) treatment options for the complex patient, such as a patient who has been diagnosed with cancer, end stage renal disease (ESRD), chronic kidney disease (CKD), or is obese.  Claim CE and MOC Credit at https://bit.ly/VTEHBCPX

Join our expert as they delve into the critical aspects of recognizing and diagnosing peripartum cardiomyopathy (PPCM), a serious heart condition affecting pregnant and postpartum women. This episode will cover guideline-directed medical therapy tailored for PPCM during pregnancy and the postpartum period. Additionally, postpartum care strategies will be explored along with a patient's personal journey to provide a comprehensive understanding of the condition.

The future of primary care in relation to COVID-19 in 2025 is shaped by several key trends and strategies. Join our speakers as they discuss resilience, innovation, how to utilize the most recent application of scientific findings to ensure optimal patient outcomes and much more. CE and ABIM MOC credits available: https://bit.ly/3R2wJoi

Addressing social determinants of health (SDOH) requires a multifaceted approach involving various sectors and stakeholders. There are population groups and underlying medical conditions that can increase the risk of mild to moderate COVID-19 infection, progressing to a severe outcome. The speakers will discuss these aspects and provide strategies for change.  CE and ABIM MOC credits available:  https://bit.ly/4k0q2jY

In this episode, learn from leading experts about managing preeclampsia with and without severe features. The panel will define the pathophysiology and potential for multi-organ system impact with preeclampsia; discussion to include postpartum care recommendations. 

In this episode, hear from leading experts as they define the major health issues in hypertensive disorders of pregnancy. Learn how to outline the appropriate work-up to diagnose hypertensive disorders of pregnancy; discussion to include recommended medications as well as postpartum care. 

In this episode Dr. Paul Ridker discusses the pivotal role of high-sensitivity C-reactive protein (hsCRP), a biomarker for inflammation, in cardiovascular prevention and treatment. He explains how inflammation and cholesterol together drive atherosclerosis, the significance of hsCRP testing, and the latest clinical trial findings. Dr. Ridker also highlights the importance of primary prevention strategies and the potential of targeted anti-inflammatory therapies to revolutionize cardiovascular care.

In this episode, Dr. Brittany Weber discusses the role of inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular disease. She explores the connection between inflammation and atherosclerosis and how immune system activation contributes to atherosclerosis development, the importance of endothelial damage and pro-inflammatory cytokines, and the impact of systemic inflammatory diseases on cardiovascular risk. Tune in to learn about the mechanisms behind inflammation in cardiovascular disease and the significance of hsCRP as a biomarker.

In this episode, Dr. Amir Rezvan hosts a panel discussion with distinguished colleagues Dr. Paul Ridker, Dr. Brendan Everett, Dr. Michael Garshick, and Dr. Kaitlin Voigts Key. The panel explores what high-sensitivity CRP (hs-CRP) is and its normal levels, the role of hsCRP in diagnosing and treating atherosclerotic disease, and how inflammation and hyperlipidemia contribute to cardiovascular events. The panel provides practical advice on measuring hsCRP and interpreting high values. Tune in for this insightful discussion on the importance of hsCRP in preventive cardiology and how to effectively use this biomarker in clinical practice.

In this episode, Dr. Brendan Everett discusses how lifestyle changes can reduce low-grade systemic inflammation. He explores the impact of weight loss on high-sensitivity CRP (hs-CRP)levels, the benefits of different diet types, and the role of exercise and smoking cessation in managing inflammation. Watch now to learn how lifestyle interventions can play a crucial role in reducing inflammation and improving cardiovascular health.

In this episode, Dr. Michael Garshick discusses the role of pharmacologic interventions in managing inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular (CV) disease. Key topics include the involvement of inflammation in atherosclerosis and atherothrombosis, traditional targets such as dyslipidemia, hypertension, and antiplatelet therapy, and the complexity of targeting inflammation and the inflammasome signaling pathway. He also explores insights from the CANTOS trial on IL-1 beta inhibitors and their impact on CV events and the role of colchicine in reducing CV events and its safety profile. Watch now to learn about the latest advancements in pharmacologic strategies for reducing cardiovascular risk through inflammation management.

In this episode, Dr. Paul Ridker explores the crucial role of inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular health. He discusses the importance of measuring hsCRP and addresses common misconceptions about the variability of this biomarker. Tune in to gain a deeper understanding of how hsCRP can be a powerful tool in predicting and managing cardiovascular health.

In this episode, hear from leading experts as they define the major health issues in hypertensive disorders associated with pregnancy. Learn how to outline the appropriate work-up to diagnose hypertensive disorders in pregnancy; discussion to include postpartum care recommendations. 

This episode will focus on the challenges of living with Long COVID, including barriers to being diagnosed with the condition and ongoing issues with finding effective therapies. Patient perspectives will be highlighted. CE and ABIM MOC credits available: https://bit.ly/4eQCC2g

This vodcast explores the role of telehealth in hypertension management, covering its definition and the key components for a successful virtual visit, such as self-measured blood pressure and treatment protocols. Experts outline the essential resources required to implement a telehealth service and address important equity considerations to ensure inclusive and effective care for all patients. 

Episode 3 of the Unmet Needs in HTN Vodcast Series.   In this vodcast episode, we dissect evidence-based approaches to hypertension management, from lifestyle interventions to single-pill combination therapies. We explore implementation strategies to boost adherence to both lifestyle modifications and medication therapy, and review treatment algorithms for optimal medication use and the identification of secondary hypertension. Join us as we unravel the complexities of hypertension management, empowering healthcare professionals to optimize patient care and outcomes.  CE and MOC credits available. 

It is essential for healthcare professionals to be responsive to emerging knowledge from the scientific community to manage patients contracting the SARS-CoV-2 illness. In this episode, Dr. Jeffrey Hsu talks with Dr. Biykem Bozkurt about the cardiovascular effects of COVID-19, including myocarditis, as well as a review of the risks of myocarditis with COVID-19 vaccination. CE and ABIM MOC credits available: https://bit.ly/3WPETmB

This is Vodcast 3 of a 4 part series on Unmet Needs in Hypertension. In this vodcast episode, we dissect evidence-based approaches to hypertension management, from lifestyle interventions to single-pill combination therapies. We explore implementation strategies to boost adherence to both lifestyle modifications and medication therapy, and review treatment algorithms for optimal medication use and the identification of secondary hypertension. Join us as we unravel the complexities of hypertension management, empowering healthcare professionals to optimize patient care and outcomes.

Episode 2 in the Unmet Needs in Hypertension Vodcast Series Discussing the strategies of lifestyle management of blood pressure. In this vodcast, watch experts detail the importance of diet, exercise, and other behavioral modifications in lowering and maintaining blood pressure. 

Episode 1 of the Unmet Needs in HTN Vodcast Serries. This vodcast delves into the essentials of home blood pressure monitoring (HBPM). Experts discuss why HBPM is crucial for managing hypertension effectively and discover the various benefits it offers to patients. Join us on discussion of educating patients on selecting the right monitoring device, preparing for accurate readings, and integrating HBPM data seamlessly into their hypertension management plans, ensuring comprehensive care and improved health outcomes.

Conversation around how a cardiologist or non-endocrinologist starts GLP-1 RAs. We will explore dose escalation, concerns about hypoglycemia, managing other glucose lowering agents, how to deal with adverse effects and other important topics. Claim CE Credit at https://bit.ly/3xqdZJg 

Conversation around the barriers to GLP-1 RAS. Dr. Trudy Gaillard and Dr. Monica Peek discuss adverse effects, cost, strategies when taking with other medications, social determinants of health, and educational support. Claim CE and MOC Credit at https://bit.ly/4bmIxu0

Conversation around patient selection and GLP-1 RAs. The speakers will explore the effects of GLP-1 RAs and SGLT-2 inhibitors on clinical outcomes and CVD risk factors.  Claim CE Credit at https://bit.ly/4aSgdzz  

It has been essential for healthcare professionals to be responsive to emerging knowledge from the scientific community to manage patients contracting the SARS-CoV-2 illness.  Dr. Jeff Hsu talks with Dr. Carrie Harvey about the cardiovascular risks with COVID-19, diagnostic tools, clinical manifestations, short and long-term cardiovascular outcomes after recovery from the acute infection. Recommendations for cardiac wellness will also be discussed. Claim CE and MOC Credit at https://bit.ly/3QISie3

In this episode, a panel of experts discuss existing VTE treatment options, algorithms, corresponding safety and efficacy profiles along with safety and efficacy data, and protocols to address treatment pathways. Claim CE and MOC Credit at https://bit.ly/VTEIII

COVID-19 care is now mostly provided outside of hospital settings. Early diagnosis and therapeutic intervention for those who are at increased risk of progression to severe COVID-19 may improve outcomes. Dr. Jeff Hsu talks with Dr. Mary Brennan about the symptoms associated with the different stages of SARS-CoV-2 and choosing the appropriate outpatient therapeutic treatment.   CE and ABIM MOC credits available: https://bit.ly/3PeZRIy    

Conversation about the approved GLP-1 RAs to manage type 2 diabetes mellitus (T2DM). Forms of administration, contextualizing the many benefits and the risks, and indications will be discussed. Claim CE Credit at https://bit.ly/49Ultlu

Conversation about the global rise of obesity and its association with diabetes and the limited effectiveness of many pharmacotherapies tested for management of obesity. You will also learn about weight loss benefits, improvement in cardiovascular risk factors, and potential for cardiovascular event reduction with GLP-1RA therapy in patients with obesity.  Claim CE Credit at https://bit.ly/3OkYJm9

Conversation around current considerations for use of GLP-1 RAs in people with type 2 diabetes and chronic kidney disease (CKD). The discussion will include general considerations for management of diabetes in CKD, potential benefits of GLP-1 RA therapy in CKD (e.g., glycemic lowering, CV risk reduction, potential kidney benefits), and a discussion of contemporary guideline recommendations for GLP-1 RA use in this population. Claim CE and MOC Credit at https://bit.ly/4aNc3t8

Conversation around specific cardiovascular risks, while distinguishing between glycemic control and cardiovascular risk reduction. We will also highlight the benefits of treatment with GLP-1 RA in patients with diabetes. Claim CE and MOC Credit at https://bit.ly/45mZkdq

This activity focuses on the American Heart Association's Essential 8 and glucose control. You will learn how GLP-1 RAs accelerate these glucose control goals and contribute to cardiorenal outcomes including how they work. Claim CE and MOC Credit at https://bit.ly/47nTdqQ

HCM experts discuss the importance of shared decision-making in the treatment of patients with HCM with or at risk for arrhythmias, including patient perspectives. The prevalence of symptomatic and asymptomatic atrial fibrillation requires shared decision-making between patients and providers regarding initiation of oral anticoagulation and global management strategy (rate vs rhythm control). Likewise, this episode will highlight factors to consider when deciding on ICD placement, particularly for primary prevention of sudden cardiac death.

When patients present with symptoms such as fatigue, fainting, shortness of breath, chest pain or heart palpitations without a known cause, suspect and test for HCM. In this episode, experts will discuss the best approaches for the management of symptoms in patients with HCM.  Lean more on identifying strategies to improve provider-patient communication and utilizing shared decision-making to personalize treatment strategies. 

In this episode, a panel of experts discuss identifying appropriate risk assessment strategies to accurately determine the level of VTE risk for patients. Claim CE and MOC Credit at bit.ly/EvalPatVTE

People with HCM may need to make lifestyle changes, such as limiting their activity, to accommodate their disease. In this episode, experts will cover behavior modifications for patient with hypertrophic cardiomyopathy, including regular physical activity recommendations as well as sports participation, occupational considerations, pregnancy, and management of comorbidities.

HCM is a chronic and progressive disease that puts patients at risk of serious complications and co-morbidities.  Early detection, disease and symptom management may help improve HCM outcomes.  Learn tips and tricks for the initial diagnosis of Hypertrophic Cardiomyopathy, diagnostic testing, and referrals.

Watch a discussion among experts on the epidemiology of venous thromboembolism (VTE), including identifying patients at risk and discussing methods for the accurate diagnosis of DVT/PE as well as existing VTE treatment options, algorithms, and corresponding safety and efficiency profiles.  Claim CE and MOC Credit at bit.ly/WhatIsVTE

HeartBEATS from Lifelong Learning™ Science Series is a podcast series curated by the AHA. Experts explore highlights on the most up-to-date information to inform your clinical practice. This episode discusses the epidemiology, pathophysiology, and how to manage atrial fibrillation in heart failure with reduced ejection fraction (HFrEF).